APA
AXSM icon

American Portfolios Advisors’s Axsome Therapeutics AXSM Stock Holding History

American Portfolios Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$4.91K Sell
110
-2,525
-96% -$126K ﹤0.01% 2827
2022
Q2 		$101K Buy
2,635
+1,060
+67% +$33.5K ﹤0.01% 1398
2022
Q1 		$65.2K Hold
1,575
– – ﹤0.01% 1752
2021
Q4 		$59.5K Hold
1,575
– – ﹤0.01% 1789
2021
Q3 		$51.9K Buy
1,575
+1,500
+2,000% +$58.5K ﹤0.01% 1758
2021
Q2 		$5.06K Hold
75
– – ﹤0.01% 2809
2021
Q1 		$4.25K Hold
75
– – ﹤0.01% 2758
2020
Q4 		$6.11K Buy
+75
New +$5.61K ﹤0.01% 2327

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

American Portfolios Advisors's AXSM Position: Q3 2022 in Review

American Portfolios Advisors reduced its Axsome Therapeutics (AXSM) stake by 96% in Q3 2022, selling an estimated $126K and leaving 110 shares worth $4.91K. The position accounts for ﹤0.01% of the portfolio, ranked #2827.

American Portfolios Advisors first reported a position in AXSM in Q4 2020 and has held it in 8 quarters since. The position peaked at $101K in Q2 2022. 189 funds tracked by Wall St. Rank hold AXSM as of Q3 2022.

  • American Portfolios Advisors held 110 shares of Axsome Therapeutics worth $4.91K as of Q3 2022.
  • American Portfolios Advisors sold 2,525 Axsome Therapeutics shares in Q3 2022, an estimated $126K.
  • Axsome Therapeutics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2827 holding.
  • American Portfolios Advisors first reported a position in Axsome Therapeutics in Q4 2020 and has held it in 8 quarters since.
  • American Portfolios Advisors's Axsome Therapeutics position peaked at $101K in Q2 2022.
  • 189 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.